The “Global Male Infertility Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026” research study available on Decisiondatabases.com gives a detailed evaluation of the market flow and the market dynamics of the global male infertility market. The report foresees the global male infertility market to reach over USD 4.7 BN by 2026 along with a CAGR of 5.4% from 2020-2026. The market was valued close to USD 3.4 BN in 2019.
Male infertility is a term used to define the inability of a male to impregnate his female partner after a year of unprotected intercourse. Infertility in males is characterized by various infertility related problems such as low sperm count, presence of low motile sperm or azoospermia. The various reasons leading to male infertility are stress, consumption of alcohol or drugs, smoking, obesity and environmental toxins. In some cases, male infertility is caused due to testicular damage leading to the inability of the testicles to produce sperms. The damaged testicle is generally unable to regain its sperm-making capacity and this trait of male infertility is comparable to menopause. When an individual is diagnosed with infertility, the individual undergoes immense stress, embarrassment and guilt which would further deepen the issue of infertility. Other factors causing male infertility include heat stress, lack of sleep and exposure to heavy metals, electromagnetic radiation and mycotoxins. The treatment for male infertility depends on its cause and it can be treated via surgery, hormone therapy and assisted reproductive technologies (ART).
The rise in the prevalence of infertility rates across the globe and the growth in the adoption of assisted reproductive technologies (ART) are the factors responsible for the growth in the global male infertility market. The advancements in technology and the expenditure by individuals has also increased the demand for male infertility treatments. The demand for male infertility treatment has also increased due to the awareness among people to treat their health problems and the urge to overcome social taboo. However, the high cost of the treatments may hamper the growth of the global male infertility market.
By test, DNA fragmentation technique, oxidative stress analysis, microscopic examination, sperm agglutination, computer-assisted semen analysis and sperm penetration assay are the segments of the global male infertility market.
By treatment, assisted reproductive technology and medication are the classifications provided for the global male infertility market as per the study.
By geography, North America, Europe, Asia Pacific, Latin America and Middle East & Africa are the segments of the global male infertility market.
The report also offers a the complete competitive outlook of the worldwide market with company profiles of key players such as Andrology Solutions, Aytu BioScience, Inc., Bayer Group, Cadila Healthcare Ltd., EMD Sereno, Inc., Endo International plc, Halotech DNA SL, Intas Pharmaceuticals Ltd., Sanofi, and SCSA Diagnostics, Inc. along with information in terms of their future capabilities, key mergers & acquisitions, financial outline, partnerships and product launches & developments.
Other Related Reports:
Global Healthcare Analytics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026
Global Health Ingredients Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026
About Us:
DecisionDatabases.com is one stop shop for your Market research requirements like market reports, company profiles and Industry databases. Our team consists of expert Business Analysts who have been trained to map your research requirement to the correct research resource.
For more details:
DecisionDatabases.com
E-Mail: [email protected]
Phone: +91 9028057900
Web: https://www.decisiondatabases.com/